Further treatmenta | Sinus tract | Non-sinus tract | ||
---|---|---|---|---|
Total (n = 19) | Successb 7 (36.8%) | Total (n = 15) | Successb 10 (66.7%) | |
Suppressive antibiotic therapy | 5 (26.3%) | – | 3 (20.0%) | – |
Multiple DAIR | 6 (31.6%) | 3 (50.0%) | 1 (6.7%) | 1(100.0%) |
One-stage exchange revision | 3 (15.8%) | 2 (66.7%) | 0 (0.0%) | – |
Two-stage exchange revision | 5 (26.3%) | 2 (40.0%) c | 11 (73.3%) | 9 (81.8%) |